Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand DNA breaks in edited cells.

Ginkgo Bioworks Holdings, Inc. (DNA) shares ended the last trading session 14.5% higher at $16.36. The jump came on an impressive volume with a higher-than-average number of shares changing hands in ...

The world’s first genetically edited polo horses are here, all thanks to the efforts of a biotech firm based in Argentina. Kheiron Biotech – a firm based in Buenos Aires – has used the CRISPR-Cas9 ...

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

TriLink BioTechnologies & Aldveron ink non-exclusive license and supply agreement for CleanCap mRNA capping technology: San Diego, US Thursday, February 6, 2025, 15:00 Hrs [IST] T ...

Applied DNA Sciences (NASDAQ:APDN – Get Free Report) is expected to issue its quarterly earnings data before the market opens ...

Analysts at HC Wainwright increased their FY2024 earnings per share estimates for shares of Evaxion Biotech A/S in a note issued to investors on Monday, February 3rd. HC Wainwright analyst S.

Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines.